Boguslawa Karaszewska
Konin, LD, Poland
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 19 publications
Five-Year Outcomes With Pembrolizumab Versus Chemotherapy as First-Line Therapy in Patients With Non-Small-Cell Lung Cancer and Programmed Death Ligand-1 Tumor Proportion Score ≥ 1% in the KEYNOTE-042 Study.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: October 28, 2022
Atezolizumab with enzalutamide versus enzalutamide alone in metastatic castration-resistant prostate cancer: a randomized phase 3 trial.
Journal: Nature medicine
Published: April 23, 2021
Subcutaneous trastuzumab with pertuzumab and docetaxel in HER2-positive metastatic breast cancer: Final analysis of MetaPHER, a phase IIIb single-arm safety study.
Journal: Breast cancer research and treatment
Published: January 04, 2021
Role of Tumor-Infiltrating B Cells in Clinical Outcome of Patients with Melanoma Treated With Dabrafenib Plus Trametinib.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: September 22, 2020
Five-Year Outcomes with Dabrafenib plus Trametinib in Metastatic Melanoma.
Journal: The New England journal of medicine
Published: June 06, 2019
A Multicenter Phase II Study of AMG 337 in Patients with MET-Amplified Gastric/Gastroesophageal Junction/Esophageal Adenocarcinoma and Other MET-Amplified Solid Tumors.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: April 30, 2018
Three-year pooled analysis of factors associated with clinical outcomes across dabrafenib and trametinib combination therapy phase 3 randomised trials.
Journal: European journal of cancer (Oxford, England : 1990)
Published: May 16, 2017
Eltrombopag for thrombocytopenia in patients with advanced solid tumors receiving gemcitabine-based chemotherapy: a randomized, placebo-controlled phase 2 study.
Journal: International journal of hematology
Published: April 06, 2017
Chemotherapy-induced peripheral neuropathy - diagnosis, evolution and treatment.
Journal: Ginekologia polska
Published: July 29, 2016
Final overall survival analysis of a phase II trial evaluating vinorelbine and lapatinib in women with ErbB2 overexpressing metastatic breast cancer.
Journal: Breast (Edinburgh, Scotland)
Published: April 08, 2015
Comparison of dabrafenib and trametinib combination therapy with vemurafenib monotherapy on health-related quality of life in patients with unresectable or metastatic cutaneous BRAF Val600-mutation-positive melanoma (COMBI-v): results of a phase 3, open-label, randomised trial.
Journal: The Lancet. Oncology
Published: April 01, 2015
Last Updated: 09/26/2026